NATURAL HEALTH TRENDS CORP
NHTCDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 29, 2026
6dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
NHTC Earnings Report
FQ end 2026-06
How NHTC's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Heptex | Phase 2 | Nonalcoholic Steatohepatitis | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in NATURAL HEALTH TRENDS CORP's drug pipeline?→
CatalystAlert tracks 1 drug candidate in NATURAL HEALTH TRENDS CORP's (NHTC) pipeline across Phase 2. Its lead program is Heptex (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NATURAL HEALTH TRENDS CORP's next FDA catalyst?→
NATURAL HEALTH TRENDS CORP's (NHTC) next tracked catalyst is a Earnings expected July 29, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track NHTC biotech catalysts?→
Add NHTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NATURAL HEALTH TRENDS CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.